The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1281
Gluten-Free Drugs for Celiac Disease Patients
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Celiac disease is a chronic autoimmune disorder caused by a genetic intolerance to gluten that occurs in about 1% of the population.1 The main form of treatment is a lifelong gluten-free diet.

CELIAC DISEASE — Although originally described in young children as a malabsorption syndrome characterized by diarrhea, steatorrhea and failure to thrive, particularly after cereals are first introduced, presentations in older children, adolescents and adults with diarrhea or non-gastrointestinal signs and symptoms (such as iron-deficiency anemia, metabolic osteopathy, short stature, neurologic symptoms, type 1 diabetes and dermatitis herpetiformis) are now more common.2 Potential complications of celiac disease include intestinal adenocarcinoma, enteropathy-associated T-cell lymphoma and refractory sprue. The trigger for these signs, symptoms and complications is exposure of the ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Gluten-Free Drugs for Celiac Disease Patients
Article code: 1281b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian